Santa Clara, California, and Piscataway, New Jersey – November 18th, 2022. Today, Applied Cells Inc. and GenScript USA Incorporated announced their strategic collaboration to deliver combined cell isolation solutions for cell therapy drug development worldwide. Under this collaboration, GenScript will
Santa Clara, California, and Vancouver, Canada – April 19, 2022. Applied Cells Inc. and STEMCELL Technologies Canada Inc. have announced their collaboration to deliver a new high-performance cell separation solution that combines Applied Cells’ MARS® platform with STEMCELL’s EasySep™ immunomagnetic
BIOKÉ announced it has signed a distribution agreement with Applied Cells Inc to distribute the MARS® technology in the Netherlands, Belgium, and Luxembourg (Benelux), effective immediately. Applied Cells is a leading provider of cell preparation and isolation solutions for tumor
Processing solid tissue samples continues to be a major challenge to the field of Tumor Biology. Current methods are long, laborious, and harsh on fragile tumor tissue sample. Enabling a fast, gentle process can ensure precious tumor samples maintain their
Detection of Disseminating Tumor Cells (DTCs) holds promise for the early detection of potential relapse. The presence of bone marrow DTCs correlate with increased relapse risk, decreasing overall survival. Applied Cells, a commercial provider of cell preparation and isolation solutions
Santa Clara – December 2, 2020 – Applied Cells, Inc., announced today that the company will unveil its MARS® Bar System, a revolutionary fully automated high-capacity closed system for cell processing, for Early Access Program. The MARS® Bar system enables
